Neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis: A case report with a novel missense variant of SCN1A

Brain Dev. 2023 Oct;45(9):505-511. doi: 10.1016/j.braindev.2023.06.009. Epub 2023 Jul 12.

Abstract

Variants of SCN1A represent the archetypal channelopathy associated with several epilepsy syndromes. The clinical phenotypes have recently expanded from Dravet syndrome. CASE REPORT: We present a female patient with the de novo SCN1A missense variant, c.5340G > A (p. Met1780Ile). The patient had various clinical features with neonatal onset SCN1A epileptic encephalopathy, arthrogryposis multiplex congenita, thoracic hypoplasia, thoracic scoliosis, and hyperekplexia. CONCLUSION: Our findings are compatible with neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis; the most severe phenotype probably caused by gain-of-function variant of SCN1A. The efficacy of sodium channel blocker was also discussed. Further exploration of the phenotype-genotype relationship of SCN1A variants may lead to better pharmacological treatments and family guidance.

Keywords: Arthrogryposis multiplex congenita; Early infantile SCN1A epileptic encephalopathy; Early infantile developmental and epileptic encephalopathy with movement disorders; Neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis; SCN1A; Scoliosis.

Publication types

  • Case Reports

MeSH terms

  • Arthrogryposis* / genetics
  • Epilepsies, Myoclonic* / genetics
  • Epileptic Syndromes*
  • Female
  • Humans
  • Movement Disorders* / genetics
  • Mutation
  • Mutation, Missense
  • NAV1.1 Voltage-Gated Sodium Channel / genetics
  • Phenotype

Substances

  • NAV1.1 Voltage-Gated Sodium Channel
  • SCN1A protein, human